Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011
Open Biopsy in Patients With Acute Progressive Neurologic Decline and Absence of Mass Lesion
Neurol 75:419-424, Schuette,A.J., et al, 2010
Iatrogenic Creutzfeldt-Jakob Disease: The Waning of an Era
Neurol 67:389-393, Brown,P.,et al, 2006
Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
Carbamazepine Encephalopathy Masquerading as Creutzfeldt-Jakob Disease
Neurol 65:650-651, Horvath,J.,et al, 2005
Possible Transmission of Variant Creutzfeldt-Jakob Disease by Blood Transfusion
Lancet 363:417-421,411, Llewelyn,C.A.,et al, 2004
Novel Methods for Disinfection of Prion-Contaminated Medical Devices
Lancet 364:521-526, Fichet,G.,et al, 2004
Preclinical vCJD After Blood Transfusion in a PRNP Codon 129 Heterozygous Patient
Lancet 364:527-529, Peden,A.H.,et al, 2004
Extraneural Pathologic Prion Protein in Sporadic Creutzfeldt-Jakob Disease
NEJM 349:1812-1820, Glatzel,M.,et al, 2003
Sporadic Creutzfeldt-Jakob Disease and Surgery
Neurol 59:543-548, Ward,H.J.T.,et al, 2002
14-3-3 Protein Cerebrspinal Fluid Detection in Human Growth Hormone-Treated Creutzfeldt-Jakob Disease Patients
Ann Neurol 49:257-260, Brandel,J.,et al, 2001
Iatrogenic Creutzfeldt-Jakob Disease at the Millenium
Neurol 55:1075-1081, Brown,P.,et al, 2000
Surgical Treatment and Risk of Sporadic Creutzfeldt-Jakob Disease:A Case-Control Study
Lancet 353:693-697, Collins,S.,et al, 1999
Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998
Creutzfeldt-Jakob Disease after Extracranial Dura Mater Embolization for a Nasopharyngeal Angiofibroma
Neurol 48:1451-1453, Antoine,J.C.,et al, 1997
Creutzfeldt-Jakob Dis after Embolization of Intercostal Arteries with Cadaveric Dura Suggest a Syst Trans of Prion Agent
Neurol 48:1470-1471, Defebvre,L.,et al, 1997
Transmissible Spongiform Encephalopathies
NEJM 337:1821-1828, Haywood,A.M., 1997
Transmission ofr Creutzfeldt-Jakob Disease in Corneal Grafts, Exclusion Criteria Ensure Risk is Small
BMJ 315:1553-1554, Allan,B.&Tuft,S., 1997
Potential Transmission of BSE via Medicinal products
BMJ 312:988-989, Wickham,E.A., 1996
Creutzfeldt-Jakob Disease from Contaminated Growth Hormone Extracts in France
Neurol 47:690-695, Billette de Villemeur,T.,et al, 1996
Iatrogenic Creutzfeldt-Jakob Disease:An Example of the Interplay Between Ancient Genes and Modern Medicine
Neurol 44:291-293, Brown,P.,et al, 1994
"Friendly Fire"in Medicine:Hormones, Homografts, and Creutzfeldt-Jakob Disease
Lancet 340:24-27, Brown,P.,et al, 1992
Drug Induced Creutzfeldt-Jakob Like Syndrome
J Psychiatr Neurosci 17:103-105, Finelli,P.F., 1992
Creutzfeldt-Jakob Disease in a Recipient of Human Pituitary-Derived Gonadotrophin:A Second Case
JNNP 55:1094-1095, Cochius,J.I.,et al, 1992
Creutzfeldt-Jakob Disease in Pituitary Growth Hormone Recipients in the United States
JAMA 265:880-884, Fradkin,J.E.,et al, 1991
Genetic Predisposition to Iatrogenic Creutzfeldt-Jakob Disease
Lancet 337:1441-1442, Collinge,J.,et al, 1991
Creutzfeldt-Jakob Disease in a Patient with a Cadaveric Dural Graft
Neurol 41:940-941, Miyashita,K.,et al, 1991
Mortality, Neoplasia, & Creutzfeldt-Jakob Disease in Patients Treated with Human Pituitary Growth Hormone in the UK
BMJ 302:824-828, Buchanan,C.R.,et al, 1991
The Spongiform Encephalopathies, Editorial
JNNP 54:761-763, Will,R.G., 1991
Human Growth Hormone Therapy & Creutzfeldt-Jakob Disease:A Drama in Three Acts
Pediatrics 81:85-92, Brown,P., 1988
The Decline and Fall of Creutzfeldt-Jakob Disease Associated with Human Growth Hormone Therapy
Neurol 38:1135-1137, Brown,P., 1988
A Creutzfeldt-Jakob Like Syndrome Due to Lithium Toxicity
JNNP 51:120-123, Smith,S.J.M.&Kocen,R.S., 1988
Iatrogenic Creutzfeldt-Jakob Disease
Neurol 37:1520-1522, Rappaport,E.B., 1987
Creutzfeldt-Jakob Disease after Administration of Human Growth Hormone
Lancet 2:244-246, Powell-Jackson,J.,et al, 1985
Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK
JNNP 82:646-651, Heath, C.A.,et al, 2011
Clinicopath conf., Human Prion Disease, Sporadic CJD
Neurol 69:1881-1887, Geschwind,M.D., et al, 2007
Tissue Distribution of Bovine Spongiform Encephalopathy Agent in Primates after Intravenous or Oral Infection
Lancet 363:422-428,411, Herzog,C.,et al, 2004
More Than a Little Unsteady
NEJM 387:e9, Kraft, A.W.,et al, 2022
Rapid Progression of Prion Disease Associated with Transverse Myelitis
Neurol 94:e1670-e1672, Hussein, O.,et al, 2020
Precipitous Deterioration of Motor Function, Cognition, and Behavior
JAMA Neurol 74:591-596, Fernandez-Fournier, M.,et al, 2017
Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations
AJNR 37:774-781, Winton-Brown, T.T.,et al, 2016
Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Creutzfeldt-Jakob Disease (Subacute Spongiform Encephalopathy)
Adams & Victors Principles of Neurology, Chp 33, pg 769, Ropper, A.H.,et al, 2014
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Neurol 77:179-189, Lancaster, E.,et al, 2011
Clinicopath Conf, Prion Disease (Sporadic Creutzfeldt-Jakob Disease)
NEJM 353:1042-1050, Case 27-2005, 2005
Recipients of Blood or Blood Products "at vCJD risk"
BMJ 328:118-119, Bird,S.M., 2004
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Risk of Acquiring Creutzfeldt-Jakob Disease from Blood Transfusions: Systematic Review of Case-Control Studies
BMJ 321:17-19, Wilson,K. et al, 2000
An Unusual Case of Creutzfeldt-Jakob Disease
Neurol 51:617-619, Vingerhoets,F.J.G.,et al, 1998
Creutzfeldt-Jakob Disease (CJD) after Blood Product Transfusion From a Donor with CJD
Neurol 50:1872-1873, Patryk,D.,et al, 1998